Search results

Page title matches

• 20240043450. NEW COMPOUND simplified abstract (JANSSEN PHARMACEUTICA NV)
  [[:Category:JANSSEN PHARMACEUTICA NV|JANSSEN PHARMACEUTICA NV]] [[Category:JANSSEN PHARMACEUTICA NV]] ...
  3 KB (463 words) - 03:14, 9 February 2024
• Janssen Pharmaceutica NV Patent Application Trends in 2025
  == Janssen Pharmaceutica NV Patent Filing Activity == == Janssen Pharmaceutica NV patent applications in 2025 == ...
  9 KB (1,186 words) - 04:36, 28 March 2025
• Janssen Pharmaceutica NV (20240325369). TREATMENT OF METASTATIC CASTRATION-RESISTANT PROSTATE CANCER WITH NIRAPARIB simplified abstract
  [[:Category:Janssen Pharmaceutica NV|Janssen Pharmaceutica NV]] [[Category:Janssen Pharmaceutica NV]] ...
  5 KB (693 words) - 11:51, 8 October 2024
• 20240021192. SYSTEM AND METHOD FOR DETECTING COGNITIVE DECLINE USING SPEECH ANALYSIS simplified abstract (Janssen Pharmaceutica NV)
  [[:Category:Janssen Pharmaceutica NV|Janssen Pharmaceutica NV]] [[Category:Janssen Pharmaceutica NV]] ...
  4 KB (560 words) - 09:18, 19 January 2024

Page text matches

• BRCA1 patent applications on October 3rd, 2024
  [[Janssen Pharmaceutica NV (20240325369). TREATMENT OF METASTATIC CASTRATION-RESISTANT PROSTATE CANCER Organization: Janssen Pharmaceutica NV ...
  1 KB (186 words) - 11:51, 8 October 2024
• Janssen Pharmaceutica NV Patent Application Trends in 2025
  == Janssen Pharmaceutica NV Patent Filing Activity == == Janssen Pharmaceutica NV patent applications in 2025 == ...
  9 KB (1,186 words) - 04:36, 28 March 2025
• 20240043450. NEW COMPOUND simplified abstract (JANSSEN PHARMACEUTICA NV)
  [[:Category:JANSSEN PHARMACEUTICA NV|JANSSEN PHARMACEUTICA NV]] [[Category:JANSSEN PHARMACEUTICA NV]] ...
  3 KB (463 words) - 03:14, 9 February 2024
• 20240021192. SYSTEM AND METHOD FOR DETECTING COGNITIVE DECLINE USING SPEECH ANALYSIS simplified abstract (Janssen Pharmaceutica NV)
  [[:Category:Janssen Pharmaceutica NV|Janssen Pharmaceutica NV]] [[Category:Janssen Pharmaceutica NV]] ...
  4 KB (560 words) - 09:18, 19 January 2024
• Janssen Pharmaceutica NV (20240325369). TREATMENT OF METASTATIC CASTRATION-RESISTANT PROSTATE CANCER WITH NIRAPARIB simplified abstract
  [[:Category:Janssen Pharmaceutica NV|Janssen Pharmaceutica NV]] [[Category:Janssen Pharmaceutica NV]] ...
  5 KB (693 words) - 11:51, 8 October 2024
• Bedaquiline
  [[Janssen Sciences Ireland Unlimited Company]] [[Janssen Pharmaceutica Nv]] ...
  7 KB (835 words) - 11:10, 29 August 2023
• Audio Technologies patent applications on January 18th, 2024
  ...E DECLINE USING SPEECH ANALYSIS simplified abstract (Janssen Pharmaceutica NV)]] Organization: Janssen Pharmaceutica NV ...
  36 KB (5,081 words) - 09:23, 19 January 2024
• Patent Applications Report for 23rd Aug 2024
  ...nt, Inc.]] (1), [[:Category:Janssen Pharmaceutica NV|Janssen Pharmaceutica NV]] (1), [[:Category:Allergan, Inc.|Allergan, Inc.]] (1), [[:Category:Wiscons ...
  86 KB (10,804 words) - 09:41, 22 August 2024
• Blockchain patent applications on April 18th, 2024
  [[JANSSEN PHARMACEUTICA NV (20240122928). Methods For Treating Agitation In Subjects With Mild Cogniti Organization: JANSSEN PHARMACEUTICA NV ...
  313 KB (44,711 words) - 16:36, 20 April 2024
• Blockchain patent applications on April 4th, 2024
  [[Janssen Pharmaceutica NV (20240109905). 4-ALKOXY-6-OXO-PYRIDAZINE DERIVATIVES MODULATING NLRP3 simpl Organization: Janssen Pharmaceutica NV ...
  300 KB (42,649 words) - 04:05, 11 April 2024
• Blockchain patent applications on February 8th, 2024
  ...resented by the Secretary, Department of Health and Human Services, Robert Janssen of Atlanta GA (US) for The U.S.A., as Represented by the Secretary, Departm ...rocess for Forming Small Area Fill Features simplified abstract (LAYERWISE NV)]] ...
  338 KB (47,968 words) - 03:59, 9 February 2024